---
figid: PMC9332684__pharmaceuticals-15-00914-g002
pmcid: PMC9332684
image_filename: pharmaceuticals-15-00914-g002.jpg
figure_link: /pmc/articles/PMC9332684/figure/pharmaceuticals-15-00914-f002/
number: Figure 2
figure_title: ''
caption: 'Effect of montelukast on 24 h urine protein in a pre-eclampsia model in
  rats. rats/group). (a) Significant (p < 0.05) difference from the control group.
  (b) Significant (p < 0.05) difference from the Mont group. (c) Significant (p <
  0.05) difference from the L-NAME group. [Mont: montelukast; L-NAME: L-NG-Nitro arginine
  methyl ester].'
article_title: Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced
  Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway.
citation: Walaa Yehia Abdelzaher, et al. Pharmaceuticals (Basel). 2022 Aug;15(8):914.
year: '2022'

doi: 10.3390/ph15080914
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- leukotriene receptor antagonist
- L-NAME
- pre-eclampsia
- IL-6/Jak2/STAT3

---
